FDA Ventilator Recalls: Class I Events, MAUDE Deaths & Root-Cause Analysis (2024–2026)
A data-driven analysis of FDA ventilator recalls, MAUDE database adverse events, root-cause categories, and major Class I events from Vyaire, Hamilton, Baxter, and Philips.
Executive Summary
Mechanical ventilators are critical life-supporting devices used in intensive care units (ICUs), emergency transport, and home care. Because patients connected to these systems are often completely dependent on them for respiration, any mechanical or software failure presents a direct risk of patient harm.
This post-market surveillance report analyzes the FDA ventilator recall landscape, examining historical data, root causes, and patient safety events between 2024 and 2026. According to computed aggregates from official FDA databases, the ventilator category accounts for 1,556 active 510(k) clearances, 85 Premarket Approval (PMA) filings, and 643 registered recalls. The post-market risk is concentrated among a few manufacturers, led by Philips Respironics (92 recalls), Respironics California (46 recalls), Dräger Medical (27 recalls), Vyaire Medical (17 recalls), and Hamilton Medical (15 recalls).
An analysis of recall root causes shows that mechanical design failures lead the category with 174 recalls due to Device Design, followed by Process Control failures (56 recalls) and Software Design anomalies (49 recalls).
Recent safety events between 2024 and 2026 highlight these vulnerabilities. These include Vyaire’s 6.6-million-unit Class I recall in March 2024, Hamilton’s 21,000-unit Class I software recall for its C1/C2/C3/T1 platforms, and Baxter’s permanent removal of the Life2000 Ventilation System in December 2025 over a Class I cybersecurity vulnerability.
These recall events correspond with a significant volume of reports in the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. In 2024 alone, the BZD product code (non-continuous ventilator/respirator) registered 46,326 adverse event reports, while CBK (continuous ventilator, facility) registered 1,051 reports and MNS (continuous ventilator, non-life-support) registered 908 reports.
This dossier provides clinical engineers, respiratory therapists, and quality managers with a data-driven overview of ventilator safety profiles, detailing the product codes, manufacturers, and failure modes that shape post-market surveillance.
Ventilator Safety Footprint at a Glance
- Total Recalls: 643 (led by Philips Respironics — 92, Respironics California — 46, and Dräger — 27)
- Active 510(k) Clearances: 1,556 (all registered under the Anesthesiology medical specialty)
- Active PMAs: 85 (primarily high-risk home and neonate ventilation systems)
- Top Root Causes: Device Design (174), Process Control (56), Software Design (49), Nonconforming Material (41), Component Design (35)
- MAUDE Volume (2024): 46,326 reports for code BZD (home respirators), 1,051 for code CBK (ICU ventilators), 908 for code MNS (non-life support)
- Defining 2024–2026 Events: Baxter Life2000 permanent removal due to cybersecurity (Dec 2025); Vyaire 6.6M-unit AirLife resuscitator recall (Mar 2024); Hamilton C1/C2/C3/T1 software shutdowns.
Introduction: The Critical Nature of Ventilator Surveillance
Mechanical ventilators are designed to control or assist a patient’s ventilation automatically. They are classified as Class II or Class III medical devices depending on their clinical setting (facility vs. home) and the level of patient support they provide. Because these systems are life-sustaining, any malfunction—whether it is a software lockup, a battery charging failure, or a physical crack in a breathing circuit—can lead to hypoxia, hypercapnia, lung injury, or death.
Over the past few years, the ventilator market has seen significant regulatory activity. The COVID-19 pandemic led to emergency clearances and rapid production increases, which was followed by a period of increased post-market surveillance. This report compiles data from the FDA’s clearances, recalls, and MAUDE databases to outline safety trends in the ventilator category. We analyze the root causes of recalls, highlight major Class I safety alerts, and provide a comparison of safety records across the industry.
How These Numbers Were Computed
The statistics in this report are computed from official FDA datasets, including the 510(k) database, the Premarket Approval (PMA) database, the Medical Device Recalls database, and the MAUDE database.
The ventilator dataset was defined by selecting FDA product codes associated with mechanical ventilation and respiratory support. This includes:
- CBK (Ventilator, Continuous, Facility)
- NOU (Ventilator, Continuous, Minimal Ventilatory Support, Home Use)
- MNS (Ventilator, Non-Continuous, Facility Use)
- MNT (Ventilator, Non-Continuous, Home Use)
- BZD (Respirator, Non-Continuous)
- ONZ (Ventilator, Continuous, Facility Use, High-Frequency)
- QOS (Ventilator, Continuous, Home Use, Life-Support)
- BTM (Ventilator, Continuous, Home Use, Non-Life-Support)
- MOD, SFP, QOQ, QOT, QOO, BZO, QOR, LSZ, BYT, BTL, CCQ, NQY, MNR, QOV, QEB, NMC, QOW
Clearance and recall records were filtered to match these product codes. Recall counts represent individual entries in the FDA's databases, which report product-level actions. MAUDE database aggregates are based on reports submitted during the 2024 calendar year, which was the last full year of reporting prior to the FDA's transition to the new Adverse Event Reporting System (AEMS) in 2026.
The Regulatory Landscape: 510(k) and PMA Distribution
To establish the context of post-market recalls, we must first examine the pre-market clearances. Mechanical ventilators are cleared primarily through the FDA's 510(k) pathway, with a small subset of novel or high-risk devices requiring Premarket Approval (PMA).
- Active 510(k) Clearances: 1,556 clearances. All are registered under the Anesthesiology medical specialty, reflecting the historical organization of the FDA’s Center for Devices and Radiological Health (CDRH).
- Active PMAs: 85 filings and supplements. These are concentrated in high-frequency oscillatory ventilators (such as the Sensormedics 3100A/B series) and specialized neonatal ventilation systems that navigate the Class III pathway due to the clinical risks associated with premature infant respiratory care.
The distribution of active clearances is concentrated among a few major medical technology companies. While many legacy clearances remain listed under historical corporate names (such as Puritan Bennett, Nellcor, or Siemens Life Support), they are managed today by consolidated parents like Medtronic, Getinge, and Dräger.
Detailed Analysis of Key Ventilator Product Codes
Understanding the FDA's classification system is essential for analyzing the ventilator market. The FDA assigns distinct product codes based on the device's technology and clinical setting:
| Product Code | Regulatory Class | Medical Specialty | FDA Definition | Common Device Types |
|---|---|---|---|---|
| CBK | Class II (21 CFR 868.5895) | Anesthesiology | Continuous Ventilator (Facility) | ICU Ventilators (Medtronic PB980, Dräger Evita, Hamilton G5) |
| NOU | Class II (21 CFR 868.5895) | Anesthesiology | Continuous Ventilator (Home Use, Minimal Support) | Home Ventilators (Trilogy 100, Astral 150) |
| MNS | Class II (21 CFR 868.5925) | Anesthesiology | Non-Continuous Ventilator (Facility) | Emergency Transport Ventilators, Resuscitators |
| BZD | Class II (21 CFR 868.5905) | Anesthesiology | Non-Continuous Respirator (IPPB) | CPAP, BiPAP Systems, sleep apnea therapy systems |
| ONZ | Class II (21 CFR 868.5895) | Anesthesiology | Continuous Ventilator (High-Frequency) | Oscillatory neonatal ventilators (Sensormedics 3100A) |
| QOS | Class II (21 CFR 868.5895) | Anesthesiology | Continuous Ventilator (Home, Life-Support) | Advanced home ventilators (Astral, Trilogy Evo) |
| BTM | Class II (21 CFR 868.5895) | Anesthesiology | Continuous Ventilator (Home, Non-Life-Support) | Home respiratory support systems |
Recalls by Manufacturer: Leaderboard and Trends
According to the FDA's recalls database, 643 recalls have been registered for mechanical ventilators and associated breathing circuits. Segmenting these recalls by the recalling firm highlights the primary manufacturers responsible for these safety actions:
| Recalling Firm | Registered Recalls | Percentage of Recalls | Primary Affected Devices / Series |
|---|---|---|---|
| Philips Respironics, Inc. | 92 | 14.3% | Trilogy 100/200, V60, V60 Plus, Garbin System |
| Respironics California, LLC | 46 | 7.2% | Esprit Ventilator, PLV-100, V200 |
| Dräger Medical, Inc. | 27 | 4.2% | Evita Series (V500, V300, Evita 4), Babylog VN500 |
| Vyaire Medical | 17 | 2.6% | LTV Series (1200, 1150), AirLife Breathing Circuits |
| Hamilton Medical, Inc. | 15 | 2.3% | HAMILTON-C1, C2, C3, T1, G5, S1 platforms |
| Other Manufacturers | 446 | 69.4% | Tubing connectors, oxygen sensors, humidifiers, legacy platforms |
| Total Registered Recalls | 643 | 100.0% |
Recall-Year Trends (2017–2026)
Analyzing the distribution of recalls over time reveals a noticeable increase in safety actions between 2021 and 2024. This trend was driven by post-pandemic quality reviews and FDA compliance audits:
- 2017: 4 recalls
- 2018: 7 recalls
- 2019: 8 recalls
- 2020: 14 recalls
- 2021: 39 recalls (Initiation of the global Philips Respironics PE-PUR foam recall)
- 2022: 25 recalls
- 2023: 55 recalls (Focus on home-use ventilator software and battery failures)
- 2024: 54 recalls (Peak year for ventilator-specific Class I notices)
- 2025: 22 recalls (Stabilization of the market following pandemic-era corrections)
- 2026 YTD: 11 recalls (Through July 2026)
Manufacturer Profiles and Strategic Context
The commercial landscape of mechanical ventilation has been shaped by corporate mergers, structural reorganizations, and compliance challenges. Understanding the strategic background of the major players explains their post-market surveillance profiles:
1. Philips Respironics
Philips Respironics has been under significant regulatory scrutiny since its June 2021 recall of millions of CPAP, BiPAP, and ventilator devices due to the degradation of polyester-based polyurethane (PE-PUR) sound abatement foam. In 2024, Philips entered into a consent decree with the U.S. Department of Justice and the FDA, which placed strict operational restrictions on its US manufacturing facilities and required ongoing third-party audits. This regulatory focus has led to a thorough review of its product lines, resulting in additional safety notices for legacy systems like the V60 and Trilogy platforms.
2. Hamilton Medical
Hamilton Medical is a Swiss-based manufacturer known for its specialized focus on mechanical ventilation. Its systems are widely used in ICUs and air transport (EMS) settings. Hamilton is known for its closed-loop ventilation technology, specifically Adaptive Supportive Ventilation (ASV), which adjusts breath delivery based on patient lung mechanics. While Hamilton has a strong reputation for engineering, the complexity of its software architectures has led to several Class I recalls for software errors that caused unexpected shutdowns.
3. Vyaire Medical
Vyaire Medical was formed as a joint venture between Becton Dickinson and Apax Partners, absorbing the respiratory diagnostics and ventilation portfolios of CareFusion and legacy Jaeger/Bird. Vyaire focused on ICU ventilators (such as the Bellavista platform) and transport/home ventilators (the LTV series). However, after facing quality issues and post-pandemic market changes, Vyaire Medical filed for Chapter 11 bankruptcy on June 9, 2024. During the restructuring, its Ventilation Business Unit was acquired by ZOLL Medical Corporation and its Respiratory Diagnostics arm by Trudell Medical Limited, complicating the ongoing management of historical product recalls for existing customers.
4. Dräger Medical
Dräger is a German medical and safety technology company with a long history in mechanical ventilation. Its Evita and Babylog systems are widely used in critical care and neonatal ICUs. Dräger's regulatory footprint shows a consistent record of 510(k) clearances, with recalls primarily involving mechanical component wear and process control issues rather than systemic software anomalies.
5. Medtronic (Puritan Bennett)
Medtronic's respiratory division is centered on the Puritan Bennett (PB) brand, which it acquired through its merger with Covidien. The PB840 and PB980 are widely used ICU ventilators. Medtronic's regulatory focus has been on updating the software platforms of these complex machines to address errors related to sensor calibrations and mode transitions.
Root Cause Analysis of Ventilator Recalls
A review of the root causes listed in the FDA database shows that mechanical design choices and software issues are the primary drivers of ventilator recalls:
| Root Cause Category | Registered Recalls | Percentage | Primary Failure Modes |
|---|---|---|---|
| Device Design | 174 | 27.1% | Plastic cracking, valve failures, battery degradation, screen malfunctions |
| Other / Unclassified | 101 | 15.7% | Labeling updates, component modifications, packaging inconsistencies |
| Process Control | 56 | 8.7% | Assembly errors, contamination in breathing circuits, weld joint leaks |
| Software Design | 49 | 7.6% | Operating system freezes, false alarms, failure to restart, alarm silencing bugs |
| Nonconforming Material | 41 | 6.4% | Out-of-specification raw materials, plasticizer leaching, adhesive failures |
| Component Design | 35 | 5.4% | Sensor degradation, capacitor failures, circuit board trace shorts |
Mechanical design issues (174 recalls) frequently involve structural components, such as cracks in water traps or breathing circuit adapters. Software design anomalies (49 recalls) present a different clinical risk, as they can cause unexpected shutdowns or failure of the device to restart, which directly impacts patient ventilation.
MAUDE Database: Adverse Events and Death Analysis
The Manufacturer and User Facility Device Experience (MAUDE) database provides a window into the real-world safety profiles of medical devices. In 2024, the volume of reports registered under mechanical ventilator product codes was significant:
- BZD (Respirator, Non-Continuous): 46,326 reports. This code includes BiPAP, CPAP, and non-continuous home ventilators. The high volume is primarily due to reporting from the Philips Respironics PE-PUR foam recall, which generated thousands of patient reports regarding foam degradation.
- CBK (Ventilator, Continuous, Facility): 1,051 reports. These represent reports for critical care ICU ventilators. Common issues reported include software lockups, expiratory valve failures, and alarm system errors.
- MNS (Ventilator, Non-Continuous, Facility Use): 908 reports. This category covers short-term transport ventilators and emergency respirators used in emergency departments and ambulances.
The 2026 AEMS Transition
Historically, the FDA has relied on the MAUDE database for post-market surveillance. However, in 2026, the FDA is transitioning its device event reporting to the Adverse Event Reporting System (AEMS). AEMS is designed to integrate reporting across medical devices, drugs, and biologics into a unified cloud-based system. For clinical engineering departments, this transition will introduce new standardized reporting forms and faster notification timelines, though historical MAUDE records will remain accessible as a reference archive.
[!IMPORTANT] MAUDE Data Limitation: The FDA MAUDE database is a passive surveillance system. The presence of an adverse event report or death notification in MAUDE does not prove that the medical device caused the event. These reports represent allegations and clinical observations that require independent verification. They are useful for identifying safety signals but do not represent verified clinical incidence rates.
Deep Dive: Defining 2024–2026 Class I Ventilator Recalls
Between 2024 and 2026, the FDA classified several ventilator field corrections and removals as Class I, indicating a high risk of patient harm:
1. Vyaire Medical AirLife Resuscitators (~6.6 Million Units, March 2024)
Vyaire Medical recalled approximately 6.6 million AirLife bag-valve-mask (manual) resuscitators and related respiratory support devices in a March 2024 Class I action. The affected units (manufactured in 2017 or earlier) could fail to provide enough ventilation because a duckbill valve inside the device could break — a defect that can cause hypoventilation in patients relying on the resuscitator for breathing support. Vyaire notified customers with an urgent recall letter and arranged return and replacement of the affected lots.
2. Hamilton Medical C1/C2/C3/T1 Software Recall (21,000+ Units)
Hamilton Medical recalled more than 21,000 ventilators across its C1, C2, C3, and T1 platforms due to a software issue. Under specific conditions, a software anomaly could cause the ventilator to stop ventilating and display a "Hardware Error" screen. To restore ventilation, the operator had to switch the device off and back on, which created a risk of hypoxia during the restart process. Hamilton addressed this by issuing a software correction to the error-handling routine.
3. Baxter Life2000 Ventilation System Permanent Removal (December 2025)
In December 2025, Baxter Healthcare (which acquired the Life2000 line via Hillrom) issued a permanent removal notice for the Life2000 Ventilation System. This Class I action was initiated due to a cybersecurity vulnerability in the device's diagnostic software interface. The vulnerability could allow unauthorized access to the device's configuration settings, presenting a risk of altered ventilation parameters. The Life2000 line had already faced a 2024 field correction over a battery-charger dongle that could fail to charge the device; in April 2025 Baxter announced it would end manufacture, distribution, and service of the system, before the December 2025 permanent-removal notice instructed clinicians to cease use and transition patients to alternative ventilators.
4. Medtronic (Covidien) Puritan Bennett 980 Ventilator Recall
Medtronic's Covidien subsidiary managed a Class I recall of its Puritan Bennett 980 (PB980) critical care ventilator (recall Z-0351-2022, initiated November 2021). The action addressed a capacitor manufacturing-assembly error that could cause the ventilator to become inoperable or stop working as intended. Because a life-support ventilator becoming inoperative during use can lead to hypoxia or death, the FDA classified the action as Class I; the correction required locating affected units and replacing the defective component, with notification to all care environments using the PB980.
5. Philips Respironics V60 and V60 Plus Recalls
Separately from the 2021 PE-PUR foam recall, Philips Respironics has managed multiple Class I recalls of its V60 and V60 Plus ventilators tied to power issues. A 2022 action addressed an internal power fluctuation originating from the power-management printed circuit board that could cause the ventilator to shut down unintentionally, with or without a visible or audible alarm. Philips also recalled V60 and V60 Plus units over an expired adhesive that could cause the ventilator to stop providing oxygen, with or without an alarm — reinforcing why power-related shutdowns are a recurring failure mode for this platform.
Scope Boundaries: Ventilators vs. Adjacent Respiratory Devices
To prevent data overlap, it is important to distinguish mechanical ventilator recalls from safety actions affecting adjacent respiratory devices:
| Feature | Mechanical Ventilator Recalls | Philips CPAP / BiPAP Recall | Home Oxygen Concentrator Recalls |
|---|---|---|---|
| Primary Product Codes | CBK, NOU, MNS, MNT, BZD, QOS | BYS (CPAP/BiPAP Sleep Apnea) | CAI (Oxygen Concentrator) |
| Clinical Target | Patients requiring complete or partial mechanical breathing support | Patients with obstructive sleep apnea requiring airway splinting | Patients requiring supplemental oxygen therapy without mechanical support |
| Primary Failure Modes | Software freezes, valve failure, circuit disconnects | Polyurethane foam degradation, particulate inhalation | Compressor overheating, fire hazard, low purity output |
| Key Manufacturers | Medtronic, Hamilton, Dräger, Vyaire, Philips | Philips Respironics, ResMed | Invacare, Inogen, Philips |
This distinction is important because sleep apnea CPAP systems and oxygen concentrators operate under different regulatory pathways and present different post-market safety profiles.
Action Plan for Clinical Engineers and Healthcare Facilities
When a ventilator recall is issued, clinical engineering departments (Biomed) and respiratory therapy (RT) leaders should follow a structured action plan:
- Inventory Verification: Immediately query the hospital's computerized maintenance management system (CMMS) using the serial numbers, model names, and asset IDs provided in the manufacturer's recall notice.
- Quarantine Procedures: If the recall involves a product removal, locate affected devices and place them in a designated quarantine area with clear labeling ("DO NOT USE - RECALLED").
- Software Updates: For software corrections, coordinate with the manufacturer's field service representatives to schedule patches. Ensure that devices undergoing software updates are documented and tested prior to returning to service.
- Clinical Notification: Notify the medical director of respiratory care and ICU nursing leads regarding the recall details, particularly if the correction requires specific monitoring or backup ventilation protocols.
- Documentation and Reporting: Document all completed corrections, updates, and removals in the device history record (DHR). File a report with the FDA’s reporting system if the facility experiences an adverse event related to the recalled device.
Frequently Asked Questions (FAQ)
Is the Baxter Life2000 ventilator recall still active?
Yes. The Baxter Life2000 recall is a permanent removal action initiated in December 2025. Baxter has discontinued the Life2000 Ventilation System due to a combination of cybersecurity vulnerabilities and hardware reliability issues, instructing healthcare providers to cease use of the system and transition patients to alternative ventilation platforms.
Are ventilator recalls getting more frequent?
The data shows that ventilator recalls peaked in 2023 (55 recalls) and 2024 (54 recalls). This peak was followed by a decrease in 2025 (22 recalls) and 2026 YTD (11 recalls). The peak period reflected post-pandemic quality reviews, whereas the current data indicates a stabilization of quality control processes across the major manufacturers.
Where can I check if my ventilator has been recalled?
Healthcare facilities and patients can verify the recall status of their ventilators through the FDA's Medical Device Recalls Database by searching for the manufacturer's name or the device model. Additionally, manufacturers maintain dedicated product security and correction portals, such as Philips Respironics' Recall Information Center or Baxter's Product Update portal.
Conclusion: The Future of Ventilator Safety
Post-market surveillance of mechanical ventilators between 2024 and 2026 highlights the importance of software validation and hardware reliability. As ventilators become more connected and reliant on automated software routines, the risks associated with software bugs and cybersecurity vulnerabilities have increased, as demonstrated by the Hamilton software and Baxter Life2000 recalls.
For hospital clinical engineering and respiratory care teams, managing these risks requires keeping device software up to date, monitoring manufacturer safety alerts, and conducting routine PM testing.
Disclaimer: The regulatory data and analysis presented in this report are for educational and informational purposes only. MedDeviceGuide does not provide clinical, legal, or quality-system compliance advice for specific medical devices. For official filings and current recall statuses, consult the U.S. FDA’s public databases.